NCT00141050View on ClinicalTrials.gov

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

July 31, 2005

Conditions
ADHD
Interventions
DRUG

Focalin XR

Trial Locations (1)

77007

Bayou City Research, Houston

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00141050 - Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD | Biotech Hunter | Biotech Hunter